Newsletter
Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

JAMA Editor’s Summary

Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

Editor's Audio Summary by Eric D. Peterson, MD, MPH, Associate Editor, the Journal of the American Medical Association, for the March 10, 2015 issue
March 10, 2015

Spotlight on Cardiovascular Disease: Outcomes following TAVR, LDL receptor status and diabetes risk, statin intolerance, NOAC dosing, and more.

Editor’s Audio Summary by Eric D. Peterson, MD, MPH, Associate Editor, the Journal of the American Medical Association, for the March 10, 2015 issue

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Reducing Mental Health Stigma among Healthcare Professionals featuring Corey Feist Reducing mental health stigma and mental health and well-being among healthcare professionals.